Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more episode artwork

EPISODE · Jan 25, 2022 · 11 MIN

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

from JAMA Editors' Summary

Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the January 25, 2022 issue.

Episode metadata supplied by the publisher feed · Published Jan 25, 2022

Embed this episode

Ready to play

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

0:00 11:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 11 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on January 25, 2022.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!